P21 (Cerebrolysin Fragment)
A synthetic fragment of cerebrolysin's active component that promotes CNTF expression and neurogenesis. Research-stage compound for cognitive enhancement.
Quick Reference
- Primary effects
- Neuroprotection, Cognitive Enhancement
- Onset
- Days-weeks (cumulative)
- Duration
- Ongoing
- Intensity
- Research-stage
- Legal status
- Legal (US)
- Evidence level
- Community consensus
Key Compounds
Effects
What you're here for
The Science
Content generated via CMS — mechanism of action, pharmacology, and research summaries will appear here.
Dosage
Content generated via CMS — dosage tiers, timing recommendations, and form-specific guidance will appear here.
Forms & How to Use
Content generated via CMS — available forms (powder, capsule, tincture, etc.) and preparation guidance will appear here.
Safety
Content generated via CMS — contraindications, interactions, and safety profile information will appear here.
Health Disclaimer: This information is for educational purposes only and is not medical advice. Consult a qualified healthcare provider before using any substance, especially if you take medications or have a medical condition.
Legal Status
An interactive legal status map will appear here. Check legality by state and country.
Trusted Vendors
Vendor listings coming soon. We vet every vendor for third-party testing, GMP compliance, and transparent sourcing.
Key Compounds
Sources & Citations
Content generated via CMS — peer-reviewed references, clinical trials, and source links will appear here.